The Indian Journal of Pediatrics

, Volume 80, Issue 2, pp 144–148

Hyperleukocytosis: Emergency Management

Symposium on PGIMER Management Protocols on Oncological Emergencies

Abstract

Hyperleukocytosis is defined as peripheral blood leukocyte count exceeding 100,000/mm3. Acute leukemia is the most common etiology in pediatric practice. Hyperleukocytosis is a medical emergency. The increased blood viscosity, secondary to high white cell count and leukocyte aggregates, results in stasis in the smaller blood vessels. This predisposes to neurological, pulmonary or gastrointestinal complications. In addition, patients are at risk for tumor lysis syndrome due to the increased tumor burden. Initial management includes aggressive hydration, prevention of tumor lysis syndrome, and correction of metabolic abnormalities. A red cell transfusion is not indicated in a hemodynamically stable child, as it adversely affects the blood viscosity. Leukapheresis is the treatment of choice for a very high count, or in patients with symptomatic hyperleukocytosis. The technical expertise required, a relative difficult venous access in younger children, risk of anticoagulation and possible non-availability of the procedure in emergency hours are limitations of leukapheresis. However, it is a rewarding procedure and performed with relative ease in centers that perform the procedure frequently. An exchange transfusion is often a practical option when hyperleukocytosis is complicated with severe anemia. The partial exchange aids in correcting both, without the risk of volume overload or hyperviscosity, which are the limitations of hydration and blood transfusion, respectively. Etiology and management of hyperleukocytosis in relevance to the pediatric emergency room is outlined.

Keywords

Acute lymphoblastic leukemia ALL CML Hydration India Leukostasis Priapism 

References

  1. 1.
    Fischer MJ, Rheingold SR. Oncologic emergencies. In: Pizzo PA, Poplack DG, editors. Principles and practices of pediatric oncology. 6th ed. Philadelphia: Lippencott Williams and Wilkins; 2011. p. 1125–51.Google Scholar
  2. 2.
    Majhail NS, Lichtin AE. Acute leukemia with a very high leukocyte count: confronting a medical emergency. Cleve Clin J Med. 2004;71:633–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Macfarlane RJ, McCully BJ, Fernandez CV. Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis. Pediatr Nephrol. 2004;19:924–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Creutzig U, Ritter J, Budde M, Sutor A, Schellong G. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia. Cancer. 1987;60:3071–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Macdougall LG, Strickwold B. Myeloid leukaemoid reactions in South African Blacks. S Afr Med J. 1978;53:14–6.PubMedGoogle Scholar
  6. 6.
    Kerr JR, Matthews RC. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis. 2000;19:77–88.PubMedCrossRefGoogle Scholar
  7. 7.
    Lowe EJ, Pui CH, Hancock ML, Geiger TL, Khan RB, Sandlund JT. Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer. 2005;45:10–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012;26:117–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364:1844–54.PubMedCrossRefGoogle Scholar
  10. 10.
    Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol. 1985;3:1590–5.PubMedGoogle Scholar
  11. 11.
    Inaba H, Fan Y, Pounds S, et al. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer. 2008;113:522–9.PubMedCrossRefGoogle Scholar
  12. 12.
    van Furth R, van Zwet TL. Cytochemical, functional, and proliferative characteristics of promonocytes and monocytes from patients with monocytic leukemia. Blood. 1983;62:298–304.PubMedGoogle Scholar
  13. 13.
    Rajendran A, Bansal D, Marwaha RK, Singhi SC. Tumor lysis syndrome. Indian J Pediatr. 2012 Jul 1. [Epub ahead of print].Google Scholar
  14. 14.
    Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26:2767–78.PubMedCrossRefGoogle Scholar
  15. 15.
    Haase R, Merkel N, Diwan O, Elsner K, Kramm CM. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience. Klin Padiatr. 2009;221:374–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Chang MC, Chen TY, Tang JL, et al. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage. Am J Hematol. 2007;82:976–80.PubMedCrossRefGoogle Scholar
  17. 17.
    ALL-BFM 2000 Protocol, Version 12/2008, S99.Google Scholar
  18. 18.
    Bunin NJ, Kunkel K, Callihan TR. Cytoreductive procedures in the early management in cases of leukemia and hyperleukocytosis in children. Med Pediatr Oncol. 1987;15:232–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Warrier RP, Ravindranath Y, Emami A, Lusher J. Exchange transfusion for hyperleukocytosis, anemia, and metabolic abnormalities in leukemia. J Pediatr. 1981;98:338–9.PubMedGoogle Scholar
  20. 20.
    Ozdemir MA, Karakukcu M, Patiroglu T, Torun YA, Kose M. Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. Acta Haematol. 2009;121:56–62.PubMedCrossRefGoogle Scholar
  21. 21.
    Arya LS, Padmanjali KS, Sazawal S, et al. Childhood T-lineage acute lymphoblastic leukemia: management and outcome at a tertiary care center in North India. Indian Pediatr. 2011;48:785–90.PubMedCrossRefGoogle Scholar
  22. 22.
    Vaidya SJ, Advani SH, Pai SK, et al. Survival of childhood acute lymphoblastic leukemia: results of therapy at Tata Memorial Hospital, Bombay, India. Leuk Lymphoma. 1996;20:311–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Advani S, Pai S, Venzon D, et al. Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen. Ann Oncol. 1999;10:167–76.PubMedCrossRefGoogle Scholar
  24. 24.
    Kulkarni KP, Marwaha RK. Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation: perspective and lessons from a tertiary care institution in India. Asia Pac J Clin Oncol. 2011;7:185–7.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2012

Authors and Affiliations

  1. 1.Hematology/Oncology Unit, Department of Pediatrics, Advanced Pediatrics CenterPost Graduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations